Hydroxysteroid Dehydrogenase, 11-Beta Type II Antibody – Rabbit Polyclonal

11-b-hydroxysteroid dehydrogenase (11b-HSD) is a microsomal short chain dehydrogenase/reductase (SDR) which catalyzes the inter-conversion of biologically active glucocorticoid (cortisol in human and corticosterone in rats and mice) and inactive glucocorticoid (cortisone and 11-dehydrocorticosterone). Two tissue specific isoforms (11b-HSD1 and 11b-HSD2) of 11b-HSD with two different functions regarding glucocorticoid availability, have been identified. The decreased 11b-hydroxy oxidation of cortisol results in Apparent Mineralocorticoid Excess (AME) disorder which is manifested by hypertension, hypokalemia, low plasma renin activity, and responsiveness to spironolactone. AME is principally a disorder of juveniles and children with this condition oxidize cortisol to cortisone poorly but carry out the reverse process unimpaired. AME arises from mutations in the 11b-HSD2 gene. The glucocorticoids can also be produced locally by 11b-HSD1 and increased visceral accumulation of glucocorticoids results in visceral obesity, insulin resistant diabetes, hyperlipidemia and hyperphagia. 11bHSD-2 (rat 400-aa, mouse 396-aa, human 405-aa) is a ~41kD glycosylated membrane-protein present in the endoplasmic reticulum (ER). The N-terminal and C-terminal (catalytic domain) of 11b-HSD2 are in the lumen and cytoplasm of ER, respectively. 11b-HSD2 irreversibly catalyzes the dehydrogenation of active 11b-hydroxycorticoids before they occupy mineralocorticoid receptors (MR) and thus confers aldosterone selectivity for inherently nonselective MR. The enzyme is expressed in a wide array of tissues, with highest level mineralocorticoid target cells such as the renal and outer medullary collecting ducts. In mouse, rat and Human, the over-all aa seq of 11b-HSD2 is >80% identical. In mouse, the over-all aa seq of 11b-HSD2 is >80% identical to that of 11b-HSD2.

• 1. Zhou MY et al (1995) Endocrinol. 136, 3729-3734.
• 2. Albiston AL et al (1994) Mol. Cell. Endocrinol. 105, R11.
• 3. Agarwal AK et al (1995) Genomics 29, 195.
• 4. Brown RW et al (1996) Biochem. J. 313, 1007.
• 5. Mune T et al (1995) nat. Genet. 10, 394.
• 6. Masuzaki et al. (2001) Science 294, 2166;.
• 7. Odermatt et al. (1999) J. Bio. Chem. 274, 28762.
• 8. Blum et al. (2000) BBRC. 276, 428.

Small volumes of anti-Hydroxysteroid Dehydrogenase, 11-beta Type II antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS614847 is an antibody targeting Hydroxysteroid Dehydrogenase, 11-beta Type II. Also known as Rabbit Anti-Hydroxysteroid Dehydrogenase, 11-beta Type II. Reactive in Human. Host: Rabbit
Source: Human.